# Development of a clinical diagnostic model for atypical endometrial hyperplasia and endometrial carcinoma in women aged 40–60 years based on refined abnormal uterine bleeding patterns

**Authors:** Shulin Huang, Xudong Hu, Lingjuan Hu, Tingting Du, Yanchun Zhao, Jing Xiao

PMC · DOI: 10.3389/fonc.2025.1684604 · Frontiers in Oncology · 2025-12-19

## TL;DR

This study creates a diagnostic model to predict endometrial issues in women aged 40–60 with abnormal bleeding, using clinical and bleeding pattern data.

## Contribution

A validated nomogram model integrating refined abnormal uterine bleeding patterns and clinical variables for early risk stratification of AEH/EC.

## Key findings

- The model achieved an AUC of 0.814 in training and 0.762 in external validation.
- High-risk patients (score ≥70.362) had a 12.46-fold increased likelihood of AEH/EC.
- The nomogram showed good calibration and clinical utility for individualized diagnostic guidance.

## Abstract

To develop and validate a diagnostic nomogram model for predicting atypical endometrial hyperplasia (AEH) and endometrial carcinoma (EC) in women aged 40–60 years with abnormal uterine bleeding (AUB), incorporating detailed bleeding patterns and clinical parameters.

This retrospective cohort study included 1,920 patients aged 40–60 years with AUB who underwent hysteroscopic evaluation across four hospital branches from 2021 to 2024. Variables were screened via univariate logistic regression followed by LASSO regression. A multivariate logistic regression model was constructed using seven selected predictors, including age, family history of cancer, endometrial thickness, menstrual blood loss, abnormal menstrual duration, intermenstrual bleeding, and postmenopausal bleeding. Internal validation was performed using bootstrap resampling; external validation was conducted using an independent cohort.

The final model demonstrated good discriminatory performance (AUC = 0.814 in the training cohort, 0.762 in external validation). Calibration plots and the Hosmer–Lemeshow test indicated good agreement between predicted and observed probabilities. Decision curve analysis confirmed favorable clinical utility. Patients classified as high-risk (score ≥70.362) had a significantly increased likelihood of AEH/EC (OR = 12.46, 95% CI: 7.56–21.01, P < 0.001).

This study presents a validated, user-friendly nomogram integrating refined AUB patterns and clinical variables to support early risk stratification for AEH/EC in women aged 40–60 years. The model demonstrates robust predictive performance and may assist in guiding individualized diagnostic strategies, particularly in resource-limited settings.

## Linked entities

- **Diseases:** atypical endometrial hyperplasia (MONDO:0006096), endometrial carcinoma (MONDO:0002447)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** menstrual blood loss (MESH:D004412), AUB (MESH:D014592), AEH (MESH:D004714), EC (MESH:D016889), cancer (MESH:D009369), bleeding (MESH:D006470)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12757285/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12757285/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12757285/full.md

---
Source: https://tomesphere.com/paper/PMC12757285